These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3769045)

  • 1. Chemotherapy of advanced gastric cancer: a study of 43 consecutive cases treated with fluorouracil, adriamycin and mitomycin C (FAM).
    Faedi M; Amadori M; Gentilini P; Ridolfi R; Ravaioli A; Amadori D; Biserni R; Bonaguri C
    Chemioterapia; 1986 Aug; 5(4):240-3. PubMed ID: 3769045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
    De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
    Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer].
    Ozeki H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Ito Y; Imajo K; Shinagawa K
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):91-5. PubMed ID: 3122669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.
    Sulkes A; Uziely B; Isacson R; Brufman G; Biran S
    Isr J Med Sci; 1988; 24(9-10):604-10. PubMed ID: 3204009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of advanced gastric carcinoma (stage IV): a randomized study of FAM versus 5-FU plus BCNU.
    Villar A; Asensio F; Candel M; Delgado F; Garcia J; Lledó S; Redón J; Roig JV; Sanchez A; Sanchis C
    Chemioterapia; 1987 Feb; 6(1):57-62. PubMed ID: 3103932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland].
    Inoue K; Horikoshi N; Mukaiyama T; Ogawa M; Kuraishi Y
    Gan No Rinsho; 1989 Mar; 35(4):481-5. PubMed ID: 2654442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma.
    Gibson MK; Holcroft CA; Kvols LK; Haller D
    Oncologist; 2005 Feb; 10(2):132-7. PubMed ID: 15709215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
    Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C
    Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of advanced stage gastric carcinoma: FAM versus chemotherapeutic regimens excluding adriamycin].
    Repetto L; Campora E; Nobile MT; Rosso R
    G Ital Chemioter; 1985; 32(1):57-8. PubMed ID: 3841661
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase II study of intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and mitomycin C for advanced nonresectable gastric cancer.
    Li M; Zhang J; Wang D; Zhong B; Tucker S; Lu C; Cheng J; Cao C; Xu J; Xu J; Pan H
    Anticancer Drugs; 2009 Nov; 20(10):941-5. PubMed ID: 19745719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A five-year-survival case in which complete response was recognized after combined chemotherapy using 5-fluorouracil, adriamycin and mitomycin C (FAM) for unresectable gastric cancer].
    Iwase K; Takenaka H; Sumimura J; Ishizaka T; Takagaki M; Bessho T; Ohata T; Inoue M; Oshima S; Tanaka T
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2235-7. PubMed ID: 1444491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
    Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Ikeda K; Usui N; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1160-4. PubMed ID: 6408998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.
    Ahlgren JD; Smith FP; Cazap E; Estevez RA; Marantz A; Woolley PV; Wilcosky T; Stein J; Schein PS
    Cancer Treat Rep; 1987 Apr; 71(4):419-20. PubMed ID: 3548959
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastric cancer: complete chemotherapy response in an elderly woman: current status of treatment.
    Hagin GD; Jain A
    Am J Gastroenterol; 1985 Nov; 80(11):835-7. PubMed ID: 3840327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combination of 5-fluorouracil, epirubicin and mitomycin C (FEM) on advanced gastric carcinoma.
    Itoh T; Sakata Y; Tamura Y; Furukohori N; Saitoh S; Suzuki H; Tsushima K; Munakata A; Yoshida Y; Takagi S
    Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1551-6. PubMed ID: 2509606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hormone-resistant metastatic carcinoma of the prostate with 5-FU, doxorubicin, and mitomycin (FAM'): a preliminary report.
    Kasimis BS; Moran EM; Miller JB; Forbes KA; Kaneshiro CA; Poblet MT; Williams JL
    Cancer Treat Rep; 1983 Oct; 67(10):937-9. PubMed ID: 6688755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
    Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.